BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593]
URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6593.htm
Number Citing Articles
1
Neha R Santucci, Miguel Saps, Miranda A van Tilburg. New advances in the treatment of paediatric functional abdominal pain disordersThe Lancet Gastroenterology & Hepatology 2020; 5(3): 316 doi: 10.1016/S2468-1253(19)30256-0
2
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problemTerapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
3
Nils Günnewich, Thorsten Rose, Kathrin Koll, Kurt Appel. Magen-Darm-Entoxin® Shows Anti-Inflammatory Effects in vitroComplementary Medicine Research 2021; 28(5): 473 doi: 10.1159/000514525
4
Kayle Dickson, Hajer Malitan, Christian Lehmann. Imaging of the Intestinal Microcirculation during Acute and Chronic InflammationBiology 2020; 9(12): 418 doi: 10.3390/biology9120418
5
Ilmaben S Vahora, Nicholas Tsouklidis, Rajat Kumar, Ravi Soni, Safeera Khan. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel SyndromeCureus 2020;  doi: 10.7759/cureus.9871
6
Gisela Chelimsky, Pippa Simpson, Liyun Zhang, Doug Bierer, Steve Komas, Balaraman Kalyanaraman, Thomas Chelimsky, Takahiro Ushida. Impaired Mitochondrial Bioenergetics Function in Pediatric Chronic Overlapping Pain Conditions with Functional Gastrointestinal DisordersPain Research and Management 2021; 2021: 1 doi: 10.1155/2021/6627864
7
Lijun Mei, Jiaoli Zhou, Yimo Su, Kunhong Mao, Jing Wu, Caicai Zhu, Ling He, Ying Cui. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndromeBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01693-w
8
Yu Zhang, Lu Zhang, Shuang Li, Xia-Xin Wu, Ya-Xin Bi, Xu Hu, Yu-Qing Chen, Yuan Yuan. Serum levels of high sensitive C-reactive protein and tumor necrosis factor-alpha in different subtypes of irritable bowel syndrome and their correlationWorld Chinese Journal of Digestology 2020; 28(16): 782 doi: 10.11569/wcjd.v28.i16.782
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
9
L. B. Lazebnik, E. V. Golovanova, B. A. Volel, N. V. Korochanskaya, E. A. Lyalyukova, M. V. Mokshina, S. N. Mekhtiev, O. A. Mekhtieva, Z. V. Metsaeva, D. S. Petelin, V. I. Simanenkov, S. I. Sitkin, S. V. Cheremushkin, M. V. Chernogorova, А. I. Khavkin. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of RussiaExperimental and Clinical Gastroenterology 2021; (8): 5 doi: 10.31146/1682-8658-ecg-192-8-5-117
10
Uday C Ghoshal. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatmentJournal of Gastroenterology and Hepatology 2020; 35(5): 712 doi: 10.1111/jgh.15032
11
Emanuele Sinagra, Erika Utzeri, Gaetano Cristian Morreale, Carlo Fabbri, Fabio Pace, Andrea Anderloni. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for cliniciansWorld Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
12
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez, Alba García-López. Foundations of Colorectal Cancer2022; : 435 doi: 10.1016/B978-0-323-90055-3.00031-4
13
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta, Marcello Maida. Tenapanor for the treatment of irritable bowel syndrome with constipationExpert Review of Clinical Pharmacology 2020; 13(5): 473 doi: 10.1080/17512433.2020.1762570
14
Yong Li, Tingting Yang, Qing Yao, Songsong Li, En Fang, Yankun Li, Chao Liu, Weimin Li. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like ratsNeurogastroenterology & Motility 2019; 31(5): e13556 doi: 10.1111/nmo.13556
15
Yoshiharu Uno. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel diseaseMedical Hypotheses 2019; 132: 109324 doi: 10.1016/j.mehy.2019.109324
16
Christopher Tait, Gregory S. Sayuk. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventionsEuropean Journal of Internal Medicine 2021; 84: 1 doi: 10.1016/j.ejim.2020.12.023
17
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez. Cancer Immunology2020; : 261 doi: 10.1007/978-3-030-57949-4_10
18
Biljana Radovanovic-Dinic, Snezana Tesic-Rajkovic, Sasa Grgov, Gordana Petrovic, Valentina Zivkovic. Irritable bowel syndrome - from etiopathogenesis to therapyBiomedical Papers 2018; 162(1): 1 doi: 10.5507/bp.2017.057
19
Yu Zhang, Xia‐Xin Wu, Shuang Li, Jin‐Feng Wu, Sen Han, Zhi‐Jie Lin, Shi‐Zhen Ding, Wei‐Juan Gong. Peroxiredoxin 1 as an inflammatory marker in diarrhea‐predominant and postinfectious irritable bowel syndromeNeurogastroenterology & Motility 2020; 32(2) doi: 10.1111/nmo.13741
20
Vassilia Theodorou, Catherine Beaufrand, Sophie Yvon, Guylaine Laforge, Yvonne Burmeister, Andrea Müller, Bernd Seilheimer, Lionel Bueno, Helene Eutamene. The multicomponent medication Spascupreel attenuates stress‐induced gut dysfunction in ratsNeurogastroenterology & Motility 2020; 32(5) doi: 10.1111/nmo.13798
21
Tingting Cai, Xiang Wang, Bangjie Li, Fei Xiong, Hao Wu, Xinghao Yang. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringinPhytomedicine 2021; 86: 153527 doi: 10.1016/j.phymed.2021.153527
22
M.A. Livzan, O.V. Gaus. Fecal zonulin as a biomarker of increased intestinal permeability in patients with irritable bowel syndrome (narrative review and pilot study results)Dokazatel'naya gastroenterologiya 2021; 10(3): 47 doi: 10.17116/dokgastro20211003147